ZTS
$160.96
Zoetis Inc Cl A
($.99)
(.61%)
ZTS
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  $0.86
Revenue:  $1.72 Bil
Tuesday
Feb 16
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, November 05, 2020

What do you expect when ZTS reports earnings?
Beat
Meet
Miss

Where is ZTS's stock price going from here?
Up
Flat
Down
Stock chart of ZTS
Analysts
Summary of analysts' recommendations for ZTS
Score
Grade
Pivots
Resistance
$165.07
$164.23
$162.59

$161.75

Support
$160.11
$159.27
$157.63
Tweet
Growth
Description
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Peers
InterCeptRegeneron PharmaceuticalsVertex PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbPfizerMerck & Co.Eli LillyJohnson & JohnsonCatalent